About Index Trending news
Analyze
Pricing
Padlock Therapeutics

Padlock Therapeutics

Padlock Therapeutics

New medicines for destructive autoimmune diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$23,000,000
Venture capital (Series A)
€10,680,000
Employees

Unknown size

Locations
HQ
VentureWire

The Daily Startup: Padlock Thera Teams Up With GlaxoSmithKline

Funding
$23,000,000 Venture capital (Series A)
PE Hub

Padlock Therapeutics ropes in $23 mln Series A